Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy

References

• BirksJCholinesterase inhibitors for Alzheimer’s diseaseCochrane Database Syst Rev2006CD00559316437532
   PubMed Web of Science ®Google Scholar
• CampbellNAyubABoustaniMAImpact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: a meta-analysisClin Interv Aging2008371972819281064
   PubMed Web of Science ®Google Scholar
• SchneiderLSMangialascheFAndreasenNClinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014J Intern Med201427525128324605808
   PubMed Web of Science ®Google Scholar
• OlazaranJNavarroERojoJMPersistence of cholinesterase inhibitor treatment in dementia: insights from a naturalistic studyDement Geriatr Cogn Dis Extra20133485923637699
   PubMedGoogle Scholar
• BrewerLBennettKMcGreevyCWilliamsDA population-based study of dosing and persistence with anti-dementia medicationsEur J Clin Pharmacol2013691467147523443628
   PubMed Web of Science ®Google Scholar
• AmuahJEHoganDBEliasziwMPersistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer’s diseasePharmacoepidemiol Drug Saf20101967067920583207
   PubMed Web of Science ®Google Scholar
• SchubertCCBoustaniMCallahanCMComorbidity profile of dementia patients in primary care: are they sicker?J Am Geriatr Soc20065410410916420205
   PubMed Web of Science ®Google Scholar
• NahinRLPechaMWelmerinkDBConcomitant use of prescription drugs and dietary supplements in ambulatory elderly peopleJ Am Geriatr Soc2009571197120519515113
   PubMed Web of Science ®Google Scholar
• Indiana UniversityP450 drug interaction table2011 Available from: http://medicine.iupui.edu/clinpharm/ddis/main-tableAccessed September 17, 2014
   Google Scholar
• CampbellNBoustaniMLimbilTThe cognitive impact of anticholinergics: a clinical reviewClin Interv Aging2009422523319554093
   PubMed Web of Science ®Google Scholar
• BoudreauDMYuOGraySLRaebelMAJohnsonJLarsonEBConcomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomesJ Am Geriatr Soc2011592069207622091958
   PubMed Web of Science ®Google Scholar
• HinesLEMurphyJEPotentially harmful drug-drug interactions in the elderly: a reviewAm J Geriatr Pharmacother2011936437722078863
   PubMed Web of Science ®Google Scholar
• BachusRBickelUThomsenTRootsIKewitzHThe O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6Pharmacogenetics1999966166810634129
   PubMedGoogle Scholar
• VarsaldiFMiglioGScordoMGImpact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patientsEur J Clin Pharmacol20066272172616845507
   PubMed Web of Science ®Google Scholar
• NoetzliMGuidiMEbbingKRelationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrationsTher Drug Monit20133527027523503455
   PubMed Web of Science ®Google Scholar
• EisaiAricept [prescribing information]Woodcliff Lake, NJEisai2013 Available from: http://www.aricept.com/docs/pdf/aricept_PI.pdfAccessed September 17, 2014
   Google Scholar
• Janssen PharmaceuticalsRazadyne [prescribing information] Available from: http://www.razadyneer.com/sites/default/files/shared/pi/razadyne_er.pdfAccessed September 17, 2014
   Google Scholar
• Klimkowicz-MrowiecAWolkowPSadoMInfluence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s diseaseNeuropsychiatr Dis Treat201391029103323950644
   PubMed Web of Science ®Google Scholar
• NoetzliMEapCPharmacodynamic, pharmacokinetic, and pharmacogenetic aspects of drugs used in the treatment of Alzheimer’s diseaseClin Pharmacokinet20135222524123408070
   PubMed Web of Science ®Google Scholar
• SeripaDBizzarroAPilottoARole of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer’s diseasePharmacogenet Genomics20112122523020859244
   PubMed Web of Science ®Google Scholar
• AlbaniDMartinelli BoneschiFBiellaGReplication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer’s disease patientsJ Alzheimers Dis20123074574922465999
   PubMed Web of Science ®Google Scholar
• HicksJKSwenJJThornCFClinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsClin Pharmacol Ther20139340240823486447
   PubMed Web of Science ®Google Scholar
• CampbellNLDexterPPerkinsAJMedication adherence and tolerability of Alzheimer’s disease medications: study protocol for a randomized controlled trialTrials20131412523782591
   PubMed Web of Science ®Google Scholar
• BoustaniMAFrameAMungerSConnecting research discovery with care delivery in dementia: the development of the Indianapolis Discovery Network for DementiaClin Interv Aging2012750951623204843
   PubMed Web of Science ®Google Scholar
• OtteJLSkaarTCWuJMedication use in breast cancer survivors compared to midlife womenSupport Care Cancer2013211827183323397094
   PubMed Web of Science ®Google Scholar
• BoustaniMCampbellNMungerSMaidmentIFoxCThe impact of anticholinergics on the aging brain: a review and practical applicationAging Health20084311320
   Google Scholar
• CampbellNLBoustaniMALaneKAUse of anticholinergics and the risk of cognitive impairment in an African American populationNeurology20107515215920625168
   PubMed Web of Science ®Google Scholar
• CaiXCampbellNKhanBCallahanCBoustaniMLong-term anticholinergic use and the aging brainAlzheimers Dement2013937738523183138
   PubMed Web of Science ®Google Scholar
• LoveRRDestaZFlockhartDCYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancerSpringerplus201325223476897
   PubMedGoogle Scholar
• GaedigkASimonSDPearceREBradfordLDKennedyMJLeederJSThe CYP2D6 activity score: translating genotype information into a qualitative measure of phenotypeClin Pharmacol Ther20088323424217971818
   PubMed Web of Science ®Google Scholar
• PerkinsAJKroenkeKUnutzerJCommon comorbidity scales were similar in their ability to predict health care costs and mortalityJ Clin Epidemiol2004571040104815528055
   PubMed Web of Science ®Google Scholar
• GurwitzJHAvornJThe ambiguous relation between aging and adverse drug reactionsAnn Intern Med19911149569662024864
   PubMed Web of Science ®Google Scholar
• GardetteVAndrieuSLapeyre-MestreMPredictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer’s disease: a 2-year prospective, multicentre, cohort studyCNS Drugs20102443144220369907
   PubMed Web of Science ®Google Scholar